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Following the discovery of nerve growth factor (NGF) in 1960 1 , it was not long before its capacity to support the development of selective neuronal populations was demonstrated. Rapidly, NGF became considered as the founder member of a family of growth factors as other neurotrophins, BDNF, NT3 and subsequently NT4/5, were identified. However, it was not until the 1980s that the first receptor for NGF was described 2 . This receptor was initially thought to be specific for NGF but as other members of the neurotrophin family were described it became clear that it could bind all neurotrophins and as such it became known as the neurotrophic receptor p75 (p75 NTR ). The transcendence of the identification of p75 NTR was somehow devalued by the lack of any obvious catalytic motif within its cytoplasmic domain. Indeed, when the Trk family of receptor tyrosine kinases was shown to specifically bind and transduce the trophic signals initiated by the neurotrophins 3 , p75
NTR became a secondary player in studies of the neurotrophin family.
A resurgence in the interest in p75 NTR was sparked by the discovery of several homologs, many of which were able to induce apoptosis upon ligand binding (i.e. Fas and the TNF receptor among others). All the members of the p75 NTR family contain cysteine-rich motifs in their extracellular domains, a single transmembrane domain, and many contain a motif in their intracellular sequence that is referred to as the death domain (Fig. 1) . Based on these structural homologies, several laboratories have tried to find evidence that p75 NTR was capable of inducing cell death. The first indication of this came to light in 1993 when the group of Bredesen 4 described p75 NTR -induced apoptosis, independent of neurotrophin binding in immortalized rat nigral neural cells. Such a ligand-independent effect was confirmed in a few other experimental paradigms but these studies did not rule out an autocrine source of neurotrophins as the cause of this apoptosis. Indeed, ligand-mediated apoptosis through p75
NTR is now widely accepted as a common cause of physiological cell death. Since then, an increasing number of examples of p75 NTR -induced cell death dependent on NGF and other neurotrophins has been shown during the past five years [5] [6] [7] . During this time, a tremendous effort has been made to identify the machinery involved in the apoptotic signalling of p75 NTR . As a result, signalling and effector molecules like ceramide, c-Jun kinase, NF-κB, Bax, some caspases, different members of the tumour necrosis factor receptor-associated factor (TRAF) family, and Fas-associated phosphatase-1 are all now known to participate in the apoptotic programme initiated by p75
NTR (Refs 5, 8) . However, a more recent advance in the analysis of the apoptotic signalling of p75 NTR has demonstrated that p75 NTR can interact with molecules involved in the regulation of the cell cycle (Fig. 1) . This raises the intriguing possibility that the apoptotic effect of p75 NTR may be secondary to conflicting signals for cell division and growth arrest . Indeed, the inappropriate activation of cell cycle regulatory molecules is known to induce the expression of p19 ARF , which subsequently activates p53 and leads to apoptosis via a pathway independent of DNA damage 12 .
The molecular links between p75
NTR and the perturbations in the cell cycle are becoming clearer. As such, the zinc finger transcription factor SC-1 has been shown to interact with the intracellular domain of p75 NTR . Following the binding of NGF, SC-1 is translocated to the nucleus 13 , an event that is associated with an absence of BrdU incorporation, although unfortunately, no effects on cell death were described in this study. 
